The loss of myoepithelial marker expression (e.g., p63, SMMHC) in the fibrovascular core or periphery of the lesion generally suggests papillary carcinoma over benign papilloma (9, 10). This evidence concerns the gene MYH11 and thyroid gland papillary carcinoma.